Christopher Peetz - 23 Jul 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: MIRM
Reported as of: 23 Jul 2024
Net transaction value: +$99,862
SEC form: 4
Accepted by SEC: 24 Jul 2024, 17:32:48 UTC
Prior SEC filing: 20 May 2024
Next SEC filing: 14 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Judit Ryvkin, Attorney-in-Fact

Key filing fact

Christopher Peetz filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 24 Jul 2024.

Key facts

This page summarizes Christopher Peetz's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2024, 17:32.

Change

Previous filing in this sequence was filed on 20 May 2024.
Current net transaction value: +$99,862.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MIRM transaction

Common Stock

Options Exercise

Transaction value: $99,862
Shares: +34,013
Change %: +37%
Price: $2.94^*
Shares after: 126,783
Date: 23 Jul 2024
Ownership: Direct

MIRM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 208,570
Date: 23 Jul 2024
Ownership: By The Peetz Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIRM transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -34,013
Change %: -11%
Price: $0.000000
Shares after: 278,487
Date: 23 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,013
Exercise price: $2.94
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/4th of the shares vested one year after November 5, 2018, and the balance of the shares vested in a series of 36 successive equal monthly installments at the end of each month thereafter.